Company Limited and Subsidiaries hereafter refer as (The Company) would like to clarify the Company’s operating results for the year ended December 31, 2019. The Company had the net profit of 50.94 million
Manager of The Stock Exchange of Thailand Union Petrochemical Public Company Limited and its subsidiaries ("the Company") would like to clarify the operating results for the Year 2019 ended December 31
Exchange of Thailand The operating performance for three-month period ended 31 March 2017 of Mahachai Hospital Public Company Limited was highlighted as follow: Company performance for three-month period
increase loss of 3%. The Company would like to clarify a significance change of the Group’s operating results were summarized as follows: 1. Revenue from sales and services for the six-month period of 2017
Subsidiaries Financial Statement as of June 30, 2017. MDX Public Company Limited (“MDX”) would like to explain major factors that affect Q2/2017 consolidated operating results as follows: ▪ MDX has THB 33.06
Entertainment Private 4. Type of Business: Entertainment Business 5. Type of transaction: To terminate investment in 17,896,666 shares of PVR BLUO Entertainment Limited since operating performance and the
Limited would like to clarify the operating results of the Quarter ended September 30, 2017 that net Profit of Baht 155.55 million, comparing to the same Quarter of previous year that has net profit Baht
. Administrative expenses at 40.91 million baht, an increase of 19.05 million baht or 87%. the company has increased from operating expenses. 3. Allowance for doubtful accounts (11.39) million baht which decrease
Subsidiaries Financial Statement as of September 30, 2017. MDX Public Company Limited (“MDX”) would like to explain major factors that affect Q3/2017 consolidated operating results as follows: ▪ In Q3/2017, one
(Angthong) 3 Limited 23/08/2021 17:59 Joint Investment for operating Liquefied Natural Gas (LNG) Business 17/09/2020 18:21 Information Memorandum on Asset Acquisition from Investment in the Development of 7